Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.40185 | 70 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.51771 | 71 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.27158 | 69 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.33856 | 69 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.38116 | 70 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.46997 | 71 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.04291 | 66 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.24745 | 69 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.26398 | 69 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.29028 | 69 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.58602 | 72 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.43221 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.24543 | 69 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.39975 | 71 |